218 related articles for article (PubMed ID: 10980274)
1. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine.
Ciccocioppo R; Angeletti S; Sanna PP; Weiss F; Massi M
Eur J Pharmacol; 2000 Sep; 404(1-2):153-9. PubMed ID: 10980274
[TBL] [Abstract][Full Text] [Related]
2. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
Sakoori K; Murphy NP
Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
[TBL] [Abstract][Full Text] [Related]
3. Expression of morphine-conditioned place preference is more vulnerable than naloxone-conditioned place aversion to disruption by nociceptin in mice.
Sakoori K; Murphy NP
Neurosci Lett; 2008 Oct; 443(2):108-12. PubMed ID: 18662746
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats.
Sandin J; Georgieva J; Schött PA; Ogren SO; Terenius L
Eur J Neurosci; 1997 Jan; 9(1):194-7. PubMed ID: 9042583
[TBL] [Abstract][Full Text] [Related]
5. Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats.
Kotlinska J; Rafalski P; Biala G; Dylag T; Rolka K; Silberring J
Eur J Pharmacol; 2003 Aug; 474(2-3):233-9. PubMed ID: 12921868
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ: role in nociceptive information processing.
Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
[TBL] [Abstract][Full Text] [Related]
7. Orphanin FQ/nociceptin blocks acquisition of morphine place preference.
Murphy NP; Lee Y; Maidment NT
Brain Res; 1999 Jun; 832(1-2):168-70. PubMed ID: 10375664
[TBL] [Abstract][Full Text] [Related]
8. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice.
Kest B; Hopkins E; Palmese CA; Chen ZP; Mogil JS; Pintar JE
Neuroscience; 2001; 104(1):217-22. PubMed ID: 11311544
[TBL] [Abstract][Full Text] [Related]
9. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion.
Devine DP; Reinscheid RK; Monsma FJ; Civelli O; Akil H
Brain Res; 1996 Jul; 727(1-2):225-9. PubMed ID: 8842403
[TBL] [Abstract][Full Text] [Related]
10. Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test.
Sandrini M; Vitale G; Pini LA; Lopetuso G; Romualdi P; Candeletti S
Eur J Pharmacol; 2005 Jan; 507(1-3):43-8. PubMed ID: 15659293
[TBL] [Abstract][Full Text] [Related]
11. Influence of nociceptin(1-17) fragments and its tyrosine-substituted derivative on morphine-withdrawal signs in rats.
Kotlinska J; Dylag T; Rafalski P; Talarek S; Kosior M; Silberring J
Neuropeptides; 2004 Oct; 38(5):277-82. PubMed ID: 15464192
[TBL] [Abstract][Full Text] [Related]
12. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat.
Hao JX; Wiesenfeld-Hallin Z; Xu XJ
Neurosci Lett; 1997 Feb; 223(1):49-52. PubMed ID: 9058420
[TBL] [Abstract][Full Text] [Related]
13. The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats.
Ciccocioppo R; Economidou D; Fedeli A; Massi M
Physiol Behav; 2003 Jun; 79(1):121-8. PubMed ID: 12818717
[TBL] [Abstract][Full Text] [Related]
14. Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro.
Zheng F; Grandy DK; Johnson SW
Br J Pharmacol; 2002 Aug; 136(7):1065-71. PubMed ID: 12145107
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis.
Devine DP; Watson SJ; Akil H
Neuroscience; 2001; 102(3):541-53. PubMed ID: 11226692
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin/orphanin FQ and drugs of abuse.
Ciccocioppo R; Angeletti S; Panocka I; Massi M
Peptides; 2000 Jul; 21(7):1071-80. PubMed ID: 10998542
[TBL] [Abstract][Full Text] [Related]
17. The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin.
Ahmadi S; Liebel JT; Zeilhofer HU
Eur J Pharmacol; 2001 Jan; 412(1):39-44. PubMed ID: 11166734
[TBL] [Abstract][Full Text] [Related]
18. Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses.
Sakoori K; Murphy NP
Neuropsychopharmacology; 2008 Mar; 33(4):877-91. PubMed ID: 17522627
[TBL] [Abstract][Full Text] [Related]
19. C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6).
Kotlińska J; Suder P; Sciubisz A; Łegowska A; Eilmes J; Rolka K; Silberring J
Eur J Pharmacol; 2001 May; 419(1):33-7. PubMed ID: 11348627
[TBL] [Abstract][Full Text] [Related]
20. Orphanin FQ/nociceptin blocks methamphetamine place preference in rats.
Zhao RJ; Woo RS; Jeong MS; Shin BS; Kim DG; Kim KW
Neuroreport; 2003 Dec; 14(18):2383-5. PubMed ID: 14663196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
